These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

281 related items for PubMed ID: 10613648

  • 1. Fibrinogen Bastia (gamma 318 Asp-->Tyr) a novel abnormal fibrinogen characterized by defective fibrin polymerization.
    Lounes KC, Soria C, Valognes A, Turchini MF, Soria J, Koopman J.
    Thromb Haemost; 1999 Dec; 82(6):1639-43. PubMed ID: 10613648
    [Abstract] [Full Text] [Related]

  • 2. Fibrinogen Matsumoto I: a gamma 364 Asp-->His (GAT-->CAT) substitution associated with defective fibrin polymerization.
    Okumura N, Furihata K, Terasawa F, Nakagoshi R, Ueno I, Katsuyama T.
    Thromb Haemost; 1996 Jun; 75(6):887-91. PubMed ID: 8822581
    [Abstract] [Full Text] [Related]

  • 3. Fibrinogen St. Gallen I (gamma 292 Gly--> Val): evidence for structural alterations causing defective polymerization and fibrinogenolysis.
    Stucki B, Schmutz P, Schmid L, Haeberli A, Lämmle B, Furlan M.
    Thromb Haemost; 1999 Feb; 81(2):268-74. PubMed ID: 10064005
    [Abstract] [Full Text] [Related]

  • 4. Normal binding of calcium to five fibrinogen variants with mutations in the carboxy terminal part of the gamma-chain.
    Furlan M, Stucki B, Steinmann C, Jungo M, Lämmle B.
    Thromb Haemost; 1996 Sep; 76(3):377-83. PubMed ID: 8883274
    [Abstract] [Full Text] [Related]

  • 5. Fibrinogen Matsumoto III: a variant with gamma275 Arg-->Cys (CGC-->TGC)--comparison of fibrin polymerization properties with those of Matsumoto I (gamma364 Asp-->His) and Matsumoto II (gamma308 Asn-->Lys).
    Terasawa F, Okumura N, Higuchi Y, Ishikawa S, Tozuka M, Ishida F, Kitano K, Katsuyama T.
    Thromb Haemost; 1999 May; 81(5):763-6. PubMed ID: 10365751
    [Abstract] [Full Text] [Related]

  • 6. Heterozygous abnormal fibrinogen Osaka III with the replacement of gamma arginine-275 by histidine has an apparently higher molecular weight gamma-chain variant.
    Yoshida N, Imaoka S, Hirata H, Matsuda M, Asakura S.
    Thromb Haemost; 1992 Nov 10; 68(5):534-8. PubMed ID: 1455400
    [Abstract] [Full Text] [Related]

  • 7. The mutation in fibrinogen Bicêtre II (gamma Asn308-->Lys) does not affect the binding of t-PA and plasminogen to fibrin.
    Grailhe P, Boyer-Neumann C, Haverkate F, Grimbergen J, Larrieu MJ, Anglés-Cano E.
    Blood Coagul Fibrinolysis; 1993 Oct 10; 4(5):679-87. PubMed ID: 8292717
    [Abstract] [Full Text] [Related]

  • 8. A congenitally abnormal fibrinogen (Vlissingen) with a 6-base deletion in the gamma-chain gene, causing defective calcium binding and impaired fibrin polymerization.
    Koopman J, Haverkate F, Briët E, Lord ST.
    J Biol Chem; 1991 Jul 15; 266(20):13456-61. PubMed ID: 2071611
    [Abstract] [Full Text] [Related]

  • 9. Dysfibrinogen Kagoshima with the amino acid substitution gammaThr-314 to Ile: analyses of molecular abnormalities and thrombophilic nature of this abnormal molecule.
    Niwa K, Mimuro J, Miyata M, Sugo T, Ohmori T, Madoiwa S, Tei C, Sakata Y.
    Thromb Res; 2008 Jul 15; 121(6):773-80. PubMed ID: 17854865
    [Abstract] [Full Text] [Related]

  • 10. Fibrinogen Haifa: fibrinogen variant with absence of protective effect of calcium on plasmin degradation of gamma chains.
    Soria J, Soria C, Samama M, Tabori S, Kehl M, Henschen A, Nieuwenhuizen W, Rimon A, Tatarski I.
    Thromb Haemost; 1987 Jun 03; 57(3):310-3. PubMed ID: 2958955
    [Abstract] [Full Text] [Related]

  • 11. Gene analyses of abnormal fibrinogens with a mutation in the gamma chain.
    Mimuro J, Muramatsu S, Maekawa H, Sakata Y, Kaneko M, Yoshitake S, Okuma M, Ito Y, Takeda Y, Matsuda M.
    Int J Hematol; 1992 Oct 03; 56(2):129-34. PubMed ID: 1421174
    [Abstract] [Full Text] [Related]

  • 12. Fibrinogen Matsumoto V: a variant with Aalpha19 Arg-->Gly (AGG-->GGG). Comparison between fibrin polymerization stimulated by thrombin or reptilase and fibrin monomer polymerization.
    Tanaka H, Terasawa F, Ito T, Tokunaga S, Ishida F, Kitano K, Kiyosawa K, Okumura N.
    Thromb Haemost; 2001 Jan 03; 85(1):108-13. PubMed ID: 11204560
    [Abstract] [Full Text] [Related]

  • 13. Fibrinogen Milano V: a congenital dysfibrinogenaemia with a gamma 275 Arg-->Cys substitution.
    Steinmann C, Bögli C, Jungo M, Lämmle B, Heinemann G, Wermuth B, Redaelli R, Baudo F, Furlan M.
    Blood Coagul Fibrinolysis; 1994 Aug 03; 5(4):463-71. PubMed ID: 7841300
    [Abstract] [Full Text] [Related]

  • 14. Fibrinogen Bern I: substitution gamma 337 Asn-->Lys is responsible for defective fibrin monomer polymerization.
    Steinmann C, Reber P, Jungo M, Lämmle B, Heinemann G, Wermuth B, Furlan M.
    Blood; 1993 Oct 01; 82(7):2104-8. PubMed ID: 8400260
    [Abstract] [Full Text] [Related]

  • 15. Hypofibrinogenemia due to novel 316 Asp --> Tyr substitution in the fibrinogen Bbeta chain.
    Brennan SO, Wyatt JM, May S, De Caigney S, George PM.
    Thromb Haemost; 2001 Mar 01; 85(3):450-3. PubMed ID: 11307813
    [Abstract] [Full Text] [Related]

  • 16. Normal plasmic cleavage of the gamma-chain variant of "fibrinogen Saga" with an Arg-275 to His substitution.
    Yamazumi K, Terukina S, Onohara S, Matsuda M.
    Thromb Haemost; 1988 Dec 22; 60(3):476-80. PubMed ID: 2976995
    [Abstract] [Full Text] [Related]

  • 17. Fibrinogen Poissy II (gammaN361K): a novel dysfibrinogenemia associated with defective polymerization and peptide B release.
    Mathonnet F, Guillon L, Detruit H, Mazmanian GM, Dreyfus M, Alvarez JC, Giudicelli Y, de Mazancourt P.
    Blood Coagul Fibrinolysis; 2003 Apr 22; 14(3):293-8. PubMed ID: 12695754
    [Abstract] [Full Text] [Related]

  • 18. Fibrinogen Alès: a homozygous case of dysfibrinogenemia (gamma-Asp(330)-->Val) characterized by a defective fibrin polymerization site "a".
    Lounes KC, Soria C, Mirshahi SS, Desvignes P, Mirshahi M, Bertrand O, Bonnet P, Koopman J, Soria J.
    Blood; 2000 Nov 15; 96(10):3473-9. PubMed ID: 11071644
    [Abstract] [Full Text] [Related]

  • 19. Fibrinogen Longmont. A heterozygous abnormal fibrinogen with B beta Arg-166 to Cys substitution associated with defective fibrin polymerization.
    Lounes KC, Lefkowitz JB, Coates AI, Hantgan RR, Henschen-Edman A, Lord ST.
    Ann N Y Acad Sci; 2001 Nov 15; 936():129-32. PubMed ID: 11460470
    [Abstract] [Full Text] [Related]

  • 20. The polymerization of fibrin prepared from fibrinogen Haifa (gamma 275Arg----His).
    Siebenlist KR, Mosesson MW, Di Orio JP, Tavori S, Tatarsky I, Rimon A.
    Thromb Haemost; 1989 Nov 24; 62(3):875-9. PubMed ID: 2512677
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.